§ 13F · FUND PROFILE
NEA Management Company, LLC.
AUM · $1.6B (13F)Positions · 26Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$6M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | TRVI | Trevi Therapeutics, Inc. | 13.22M | $247M | 15.5% | ±0% |
| 2 | MBX | MBX Biosciences, Inc. | 3.61M | $200M | 12.6% | ±0% |
| 3 | GLUE | Monte Rosa Therapeutics, Inc. | 7.69M | $186M | 11.7% | ±0% |
| 4 | CELC | Celcuity Inc. | 1.71M | $179M | 11.3% | −25% |
| 5 | SGP | Spyglass Pharma, Inc. | 7.39M | $165M | 10.4% | ±0% |
| 6 | SVRA | Savara, Inc. | 24.47M | $151M | 9.5% | ±0% |
| 7 | ZBIO | Zenas BioPharma, Inc. | 4.02M | $102M | 6.4% | ±0% |
| 8 | COUR | Coursera, Inc. | 12.87M | $73M | 4.6% | ±0% |
| 9 | AUPH | Aurinia Pharmaceuticals, Inc. | 3.97M | $67M | 4.2% | ±0% |
| 10 | CRSP | CRISPR Therapeutics AG | 1.06M | $58M | 3.6% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE NEA SIGNAL
AC read
NEA Management Company, LLC is a Other fund managing $1.6 billion in assets. The fund runs a focused portfolio of just 26 positions.
Read the full dossier →